EUVIMEDEUVIMED entdecken
Crossref

Infective Endocarditis After Transcatheter Versus Surgical Aortic Valve Replacement

Vassili Panagides iD, Guillermo Cuervo, Jaume Llopis, Mohamed Abdel-Wahab iD, Norman Mangner iD, Gilbert Habib iD, Ander Regueiro, Carlos A Mestres, Pilar Tornos, Eric Durand, Christine Selton-Suty, Nikolaj Ihlemann und 17 weitere

Clinical Infectious Diseases · 25.01.2024 · 78 (1) · 179-187

DOI: 10.1093/cid/ciad464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 08.08.2023. Verfasst von Vassili Panagides und 28 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. Hauptthemen laut MEDLINE: Heart Valve Prosthesis Implantation, Aortic Valve Stenosis, Heart Valve Prosthesis, Endocarditis, Bacterial. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Scarce data are available comparing infective endocarditis (IE) following surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR). This study aimed to compare the clinical presentation, microbiological profile, management, and outcomes of IE after SAVR versus TAVR.

Methods

Data were collected from the “Infectious Endocarditis after TAVR International” (enrollment from 2005 to 2020) and the “International Collaboration on Endocarditis” (enrollment from 2000 to 2012) registries. Only patients with an IE affecting the aortic valve prosthesis were included. A 1:1 paired matching approach was used to compare patients with TAVR and SAVR.

Results

A total of 1688 patients were included. Of them, 602 (35.7%) had a surgical bioprosthesis (SB), 666 (39.5%) a mechanical prosthesis, 70 (4.2%) a homograft, and 350 (20.7%) a transcatheter heart valve. In the SAVR versus TAVR matched population, the rate of new moderate or severe aortic regurgitation was higher in the SB group (43.4% vs 13.5%; P < .001), and fewer vegetations were diagnosed in the SB group (62.5% vs 82%; P < .001). Patients with an SB had a higher rate of perivalvular extension (47.9% vs 27%; P < .001) and Staphylococcus aureus was less common in this group (13.4% vs 22%; P = .033). Despite a higher rate of surgery in patients with SB (44.4% vs 27.3%; P < .001), 1-year mortality was similar (SB: 46.5%; TAVR: 44.8%; log-rank P = .697).

Conclusions

Clinical presentation, type of causative microorganism, and treatment differed between patients with an IE located on SB compared with TAVR. Despite these differences, both groups exhibited high and similar mortality at 1-year follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve Prosthesis ImplantationAortic Valve StenosisHeart Valve ProsthesisEndocarditis, BacterialEndocarditisHumansAortic ValveTreatment OutcomeRisk Factors

Stichwörter der Autor:innen

SAVRTAVRheart surgeryinfective endocarditisprognosis

Autor:innen und Institutionen

  • Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Department of Genetics, Microbiology, and Statistics, University of Barcelona, Barcelona, Spain.
  • Heart Center Leipzig, University of Leipzig, Leipzig, Germany.
  • Herzzentrum Dresden, Department of Internal Medicine and Cardiology, Technische Universität Dresden, Dresden, Germany.
  • Cardiology Department, Assistance Publique des Hôpitaux de Marseille, La Timone Hospital, Marseille, France.

ORCID-Profile: Vassili Panagides, Mohamed Abdel-Wahab, Norman Mangner, Gilbert Habib, Holger Thiele, Pierre Tattevin, David Del Val

Zitieren

APA

Panagides, V., Cuervo, G., Llopis, J., Abdel-Wahab, M., Mangner, N., Habib, G., Regueiro, A., Mestres, C. A., Tornos, P., Durand, E., Selton-Suty, C., Ihlemann, N., Bruun, N., Urena, M., Cecchi, E., Thiele, H., Durante-Mangoni, E., Pellegrini, C., Eltchaninoff, H., …, & TAVI Infective Endocarditis International Registry and ICE Investigators (2024). Infective Endocarditis After Transcatheter Versus Surgical Aortic Valve Replacement. Clinical Infectious Diseases, 78(1), 179-187. https://doi.org/10.1093/cid/ciad464

Vancouver

Panagides V, Cuervo G, Llopis J, Abdel-Wahab M, Mangner N, Habib G, et al. Infective Endocarditis After Transcatheter Versus Surgical Aortic Valve Replacement. Clinical Infectious Diseases. 2024;78(1):179-187. doi:10.1093/cid/ciad464

BibTeX
@article{Panagides2024,
  author = {Panagides, Vassili and Cuervo, Guillermo and Llopis, Jaume and Abdel-Wahab, Mohamed and Mangner, Norman and Habib, Gilbert and Regueiro, Ander and Mestres, Carlos A and Tornos, Pilar and Durand, Eric and Selton-Suty, Christine and Ihlemann, Nikolaj and Bruun, Niels and Urena, Marina and Cecchi, Enrico and Thiele, Holger and Durante-Mangoni, Emanuele and Pellegrini, Costanza and Eltchaninoff, Helene and Athan, Eugene and Søndergaard, Lars and Linke, Axel and Tattevin, Pierre and Del Val, David and Quintana, Eduard and Chu, Vivian and Rodés-Cabau, Josep and Miro, Jose M and TAVI Infective Endocarditis International Registry and ICE Investigators, TAVI Infective Endocarditis International Registry and ICE Investigators},
  title = {Infective Endocarditis After Transcatheter Versus Surgical Aortic Valve Replacement},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {1},
  pages = {179--187},
  doi = {10.1093/cid/ciad464}
}
Kostenlos starten →